Company / Profit Margin
Unicycive Therapeutics, Inc. Profit Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4525.0%
FY2024
5-year range
-4525.0% / -1053.3%
FY2022-FY2024
Trend
-138.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -1053.3% to -4525.0% over the past 2 years.
Based on SEC 10-K filings.
-4525.0% in FY2024.
Declined from -1053.3% to -4525.0% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 138.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -4525.0% | -138.3% |
| FY2023 | -1898.8% | -80.3% |
| FY2022 | -1053.3% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026